Effect of Acyclovir on HIV-1 Set Point among Herpes Simplex Virus Type 2-Seropositive Persons during Early HIV-1 Infection

被引：9

作者：

Kim, H. Nina ^{[1
,4
]}

Wang, Jing ^{[7
]}

Hughes, James ^{[7
]}

Coombs, Robert ^{[2
,4
,5
]}

Sanchez, Jorge ^{[11
]}

Reid, Stewart ^{[8
,12
]}

Delany-Moretlwe, Sinead ^{[13
]}

Cowan, Frances ^{[14
]}

Fuchs, Jonathan ^{[9
,11
]}

Eshleman, Susan H. ^{[10
]}

Khaki, Leila ^{[7
]}

McMahon, Moira A. ^{[10
]}

Siliciano, Robert F. ^{[10
]}

Wald, Anna ^{[4
,7
]}

Celum, Connie ^{[3
,4
,6
]}

机构：

[1] Univ Washington, Harborview Med Ctr, Sch Med, Dept Med, Seattle, WA 98104 USA

[2] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98104 USA

[3] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98104 USA

[4] Univ Washington, Sch Publ Hlth, Dept Med, Seattle, WA 98104 USA

[5] Univ Washington, Sch Publ Hlth, Dept Lab Med, Seattle, WA 98104 USA

[6] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98104 USA

[7] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA

[8] Univ Alabama, Dept Med, Birmingham, AL 35294 USA

[9] San Francisco Dept Publ Hlth, San Francisco, CA USA

[10] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA

[11] Asociac Civil Impacta Salud & Educ IMPACTA, Lima, Peru

[12] Ctr Infect Dis Res Zambia, Lusaka, Zambia

[13] Univ Witwatersrand, Reprod Hlth Unit, Johannesburg, South Africa

[14] UCL, London, England

来源：

JOURNAL OF INFECTIOUS DISEASES | 2010年 / 202卷 / 05期

基金：

美国国家卫生研究院;

关键词：

REVERSE-TRANSCRIPTASE; SEROCONVERSION; ACQUISITION; RESISTANCE; MUTATION; COHORT; UGANDA; TRIAL; RAKAI; MEN;

D O I：

10.1086/655662

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We evaluated whether acyclovir suppression during human immunodeficiency virus type 1 (HIV-1) acquisition reduces HIV-1 set point, increases CD4 cell counts, and selects reverse-transcriptase mutations among 76 HIV-1 seroconverters identified in a placebo-controlled trial of twice-daily acyclovir (400 mg) for the prevention of HIV acquisition in herpes simplex virus type 2 (HSV-2)-seropositive persons (HIV Prevention Trials Network study 039). We found no significant difference in plasma HIV-1 RNA levels (Pp. 30) or CD4 cell counts (Pp. 85) between the acyclovir and placebo recipients. V75I and other mutations in HIV-1 reverse transcriptase reported from in vitro acyclovir studies were not observed. In conclusion, acyclovir suppression during HIV-1 seroconversion and the subsequent 6 months does not affect HIV-1 set point.

引用

页码：734 / 738

页数：5

共 50 条

[31] Herpes Simplex Virus: The Interplay Between HSV, Host, and HIV-1
Desai, Dipen Vijay
Kulkarni, Smita Shrikant
VIRAL IMMUNOLOGY, 2015, 28 (10) : 546 - 555
[32] HIV-1 DNA PROVIRAL SEQUENCES IN FRESH URINE PELLETS FROM HIV-1 SEROPOSITIVE PERSONS
LI, JJ
FRIEDMANKIEN, AE
HUANG, YQ
MIRABILE, M
CAO, YZ
LANCET, 1990, 335 (8705): : 1590 - 1591
[33] Association between cervical shedding of herpes simplex virus and HIV-1
McClelland, RS
Wang, CC
Overbaugh, J
Richardson, BA
Corey, L
Ashley, RL
Mandaliya, K
Ndinya-Achola, J
Bwayo, JJ
Kreiss, JK
AIDS, 2002, 16 (18) : 2425 - 2430
[34] Herpes simplex virus and HIV-1: deciphering viral synergy Reply
Van de Perre, Philippe
Nagot, Nicolas
Mayaud, Philippe
LANCET INFECTIOUS DISEASES, 2009, 9 (02): : 74 - 75
[35] Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
Gianella, Sara
von Wyl, Viktor
Fischer, Marek
Niederoest, Barbara
Battegay, Manuel
Bernasconi, Enos
Cavassini, Matthias
Rauch, Andri
Hirschel, Bernard
Vernazza, Pietro
Weber, Rainer
Joos, Beda
Guenthard, Huldrych F.
ANTIVIRAL THERAPY, 2011, 16 (04) : 535 - 545
[36] Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women
Baeten, Jared M.
Benki, Sarah
Chohan, Vrasha
Lavreys, Ludo
McClelland, R. Scott
Mandaliya, Kishorchandra
Ndinya-Achola, Jeckoniah O.
Jaoko, Walter
Overbaugh, Julie
AIDS, 2007, 21 (13) : 1771 - 1777
[37] Pseudotumour of the tongue caused by herpes simplex virus type 2 in an HIV-1 infected immunosuppressed patient
Husak, R
Tebbe, B
Goerdt, S
Wölfer, LU
Zeichardt, H
Stöffler-Meilicke, M
Orfanos, CE
BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (01) : 118 - 121
[38] Herpes Simplex Virus Type 2, Genital Ulcers and HIV-1 Disease Progression in Postpartum Women
Roxby, Alison C.
Drake, Alison L.
John-Stewart, Grace
Brown, Elizabeth R.
Matemo, Daniel
Otieno, Phelgona A.
Farquhar, Carey
PLOS ONE, 2011, 6 (05):
[39] Thermoreversible gel as a candidate barrier to prevent the transmission of HIV-1 and herpes simplex virus type 2
Piret, J
Gagné, N
Perron, S
Désormeaux, A
Tremblay, MJ
Gourde, P
Omar, RF
Bergeron, MG
SEXUALLY TRANSMITTED DISEASES, 2001, 28 (08) : 484 - 491
[40] Herpes Simplex Virus Type 2 Enhances HIV-1 Susceptibility by Affecting Langerhans Cell Function
de Jong, Marein A. W. P.
de Witte, Lot
Taylor, Maureen E.
Geijtenbeek, Teunis B. H.
JOURNAL OF IMMUNOLOGY, 2010, 185 (03): : 1633 - 1641

← 1 2 3 4 5 →